17-β-estradiol inhibits transforming-growth-factor-β-induced MCF-7 cell migration by Smad3-repression
Authors:
- Ronald GustRGRonald Gust
- Burkhard KleuserBKBurkhard Kleuser
- 1 March 2006
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 534 (1-3) , 39-47
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesisOncogene, 2005
- Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cellsJournal of Endocrinology, 2005
- Involvement of Smad Signaling in Sphingosine 1-Phosphate-mediated Biological Responses of KeratinocytesJournal of Biological Chemistry, 2004
- Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasionCritical Reviews in Oncology/Hematology, 2004
- Prognostic Significance of Transforming Growth Factor β Receptor II in Estrogen Receptor-Negative Breast Cancer PatientsClinical Cancer Research, 2004
- Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4Journal of Biological Chemistry, 2002
- TGF-β signaling: positive and negative effects on tumorigenesisCurrent Opinion in Genetics & Development, 2002
- Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesisCytokine & Growth Factor Reviews, 2000
- Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasisOncogene, 1999
- Defects of TGF-β receptor signaling in mammary cell tumorigenesisJournal of Mammary Gland Biology and Neoplasia, 1996